Copyright
©The Author(s) 2020.
World J Clin Cases. Jan 6, 2020; 8(1): 97-102
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.97
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.97
Figure 1 Chest computed tomography.
A, B: Prior to initiation of pembrolizumab, with yellow arrows pointing to a left upper lobe primary measuring 14.1 cm × 10.6 cm × 14.9 cm. C, D: After 5 cycles of pembrolizumab, with yellow arrows pointing to a markedly decreased left upper lobe mass measuring 8.0 cm × 7.7 cm × 6.8 cm.
- Citation: Cimpeanu E, Ahmed J, Zafar W, DeMarinis A, Bardarov SS, Salman S, Bloomfield D. Pembrolizumab - emerging treatment of pulmonary sarcomatoid carcinoma: A case report. World J Clin Cases 2020; 8(1): 97-102
- URL: https://www.wjgnet.com/2307-8960/full/v8/i1/97.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i1.97